Name | FARMAKON, OOO |
|---|
INN | 6636006859 |
|---|
KPP | 663601001 |
|---|
OGRN | 1046602277842 |
|---|
OKPO | 72895296 |
|---|
Address | 623340, Sverdlovskaya Oblast', r-n Artinskiy, pgt Arti, ul. Avtomobilistov, d. D.1 |
|---|
Phone | 2-14-42 Contact details |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) | | 21.1 | Additional activity | Pharmaceutical substances | | 46.46 | Additional activity | Wholesale of pharmaceutical goods | | All types of activities | | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | | 47.75 | Additional activity | Retailing of cosmetics and personal hygiene products in specialized stores |
Registration date | 15.09.2004 |
|---|
Registering department | Mezhrayonnaya inspektsiya MNS Rossii N12 po Sverdlovskoy oblasti |
|---|
|
FARMAKON, OOO (Sverdlovsk Oblast; INN 6636006859) was registered on 15 Sep 2004. The company's authorized capital as of July 1, 2012 was 20000 rub. Type of ownership of FARMAKON, OOO - Limited liability companies. Form of ownership of FARMAKON, OOO - Private property. Principal activities of FARMAKON, OOO: retailing drugs in specialized stores (pharmacies) (47.73), pharmaceutical substances (21.1), wholesale of pharmaceutical goods (46.46). |
Economic indicators2023
Net profit (RAS) of FARMAKON, OOO grew over 2023 by 8.58% to 3.87 million RUB from 3.57 million RUB over 2022, the company informed. Revenue remained in the accounting period at the same level and made up 69.97 million RUB compared to 69.68 million RUB 69.68 million RUB. 2022
Net profit (RAS) of FARMAKON, OOO dropped in 2022 by 25.48% to 3.57 million RUB from 4.79 million RUB over the same period in 2021, the company informed. Revenue increased in the accounting period by 2.80% to 69.68 million RUB from 67.78 million RUB over 2021. 2021
Net profit (RAS) of FARMAKON, OOO grew over 2021 by 5.42% to 4.79 million RUB from 4.54 million RUB over 2020, the company informed. Revenue increased in the accounting period by 16.95% to 67.78 million RUB from 57.95 million RUB over 2020. 2020
Net profit (RAS) of FARMAKON, OOO grew over 2020 by 46.56% to 4.54 million RUB from 3.10 million RUB over 2019, the company informed. Revenue increased in the accounting period by 17.54% to 57.95 million RUB from 49.30 million RUB over 2019. 2019
Net profit (RAS) of FARMAKON, OOO grew over 2019 2.47 times to 3.10 million RUB from 1.25 million RUB over 2018, the company informed. Revenue increased in the accounting period by 19.56% to 49.30 million RUB from 41.24 million RUB over 2018. 2018
Net profit (RAS) of FARMAKON, OOO dropped in 2018 3.59 times to 1.25 million RUB from 4.51 million RUB over the same period in 2017, the company informed. Revenue decreased in the accounting period by 28.84% to 41.24 million RUB from 57.95 million RUB in 2017; cost of goods sold decreased by 25.86% to 39.16 million RUB from 52.81 million RUB; sales profit fell 2.47 times to 2.08 million RUB from 5.13 million RUB. 2017
Net profit (RAS) of FARMAKON, OOO dropped in 2017 2.18 times to 4.51 million RUB from 9.83 million RUB over the same period in 2016, the company informed. Revenue decreased in the accounting period by 11.76% to 57.95 million RUB from 65.67 million RUB in 2016; cost of goods sold decreased by 11.45% to 45.54 million RUB from 51.43 million RUB; sales profit fell 2.04 times to 5.13 million RUB from 10.47 million RUB. 2016
Net profit (RAS) of FARMAKON, OOO grew over 2016 1.60 times to 9.83 million RUB from 6.13 million RUB over 2015, the company informed. Revenue increased in the accounting period by 15.78% to 65.67 million RUB from 56.72 million RUB over 2015; cost of goods sold grew by 15.88% to 51.43 million RUB from 44.38 million RUB; sales profit went up 1.64 times to 10.47 million RUB from 6.39 million RUB. 2014
Net profit (RAS) of Farmakon, OOO dropped in 2014 by 29.47% to 3.52 million RUB from 4.99 million RUB over the same period in 2013, the company informed. Revenue increased in the accounting period by 12.87% to 43.32 million RUB from 38.38 million RUB over 2013; cost of goods sold grew by 15.53% to 35.08 million RUB from 30.36 million RUB; sales profit fell by 14.03% to 4.29 million RUB from 4.99 million RUB. 2013
Net profit (RAS) of Farmakon, OOO dropped in 2013 by 29.47% to 3.52 million RUB from 4.99 million RUB over the same period in 2012, the company informed. Revenue increased in the accounting period by 12.87% to 43.32 million RUB from 38.38 million RUB over 2012; cost of goods sold grew by 15.53% to 35.08 million RUB from 30.36 million RUB; sales profit fell by 14.03% to 4.29 million RUB from 4.99 million RUB. 2012
Net profit (RAS) of Farmakon, OOO grew over 2012 by 26.93% to 4.99 million RUB from 3.93 million RUB over 2011, the company informed. Revenue increased in the accounting period by 15.07% to 38.38 million RUB from 33.35 million RUB over 2011; cost of goods sold grew by 14.54% to 33.39 million RUB from 29.15 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|